SCI PHRAMATECH INC

Business Nature: Manufacturer

Company Overview:

SCI Pharmatech Inc. is a professional pharmaceutical company based in Taiwan, specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and specialty chemicals. The company operates its own manufacturing facilities, adhering to international quality standards such as cGMP (current Good Manufacturing Practice). They focus on providing high-quality chemical synthesis services and supplying critical raw materials to the global pharmaceutical and biotechnology industries. By integrating R&D with production capabilities, the company serves as a key supplier for drug development and commercial-scale manufacturing.

PHRAMATECH INC (Taiwan) Product Portfolio

Product Categories:

1. Pharmaceutical Intermediates and Fine Chemicals

Specialized organic compounds used as building blocks for the synthesis of Active Pharmaceutical Ingredients (APIs).

2. Active Pharmaceutical Ingredients (APIs)

High-purity chemical substances manufactured for use in finished pharmaceutical dosage forms.

3. Custom Synthesis and Contract Manufacturing Services (CDMO)

Tailored chemical synthesis services for small-molecule drug development, process optimization, and scale-up production.

4. Specialty Reagents for R&D

Advanced chemical reagents provided for laboratory research, analytical testing, and pilot-scale chemical development.

5. Nutraceutical Ingredients

High-quality raw materials and extracts supplied for the dietary supplement and functional food industries.

6. Cosmetic Raw Materials

Active ingredients and chemical additives designed for advanced skincare and dermatological applications.

Business Model Note:

PHRAMATECH INC primarily functions as a specialized chemical supplier and manufacturing partner, focusing on providing high-quality chemical solutions to global pharmaceutical, biotechnology, and industrial clients. Their product list is subject to change based on current market demand and specific client customization requirements.